Equity
Equity Analysis
Price
 Gainers & Losers
 Weekly Gainers & Losers
 Monthly Gainers & Losers
 Out & Under Performers
 Advances & Declines
 New Highs & Lows
 52 Week Highs & Lows
 Weightage
 Only Buyers & Sellers
 Historical Returns
Volume
Analysis
Exchange Holidays
News Analysis
Corporate Action
Corporate Info
Other Market
  Home   >  CORPORATE ACTION  > Board Meetings
Board   Meetings      
As On Apr 17,2025
Options:
Achyut Healthcare  
Inter alia, to transact following business: 1. To consider and ap ........
Adani Ports &Special  
Preferential Issue of shares
Advik Capital  
Audited Results Inter alia, to consider and approve:- i. to seek t ........
Ambo Agritec  
Increase in Authorised Capital Inter- alia, to transact the followi ........
Colab Platforms  
Interim Dividend
Devinsu Trading  
Audited Results
E2E Networks  
Financial Results
Emkay Taps & Cutting  
Other business matters
HDFC Asset Mngt. Co  
Final Dividend & Audited Results
HDFC Life Insurance  
Final Dividend & Audited Results & Employees Stock Option Plan ........
Himatsingka Seide  
Inter alia, to consider and approve proposal for fund raising by wa ........
IDFC First Bank  
Inter alia, to consider and approve the proposal for raising of fun ........
Indosolar  
Audited Results
Infosys  
Audited Results & Final Dividend Inter alia to : 1. Approve and take ........
Jainex Aamcol  
The Board of Directors of the Company which was scheduled to be hel ........
JIO Financial Serv.  
Final Dividend & Audited Results
Lloyds Engr Works  
Inter alia, to consider, discuss and approve various matters in con ........
Mahindra EPC Irrigat  
Audited Results
Natl.Stan  
Audited Results
Omnitex Industries  
Audited Results
Party Cruisers  
Other business matters
Royal Sense  
Inter-alia to transact the following business items with the permis ........
Sanathnagar Enterpri  
Audited Results
Shrenik  
Financial Results/Other business matters
Sumeru Industries  
Inter alia, to consider and approve:- 1. to pay condolence to the ........
Swadeshi Inds & Leas  
Preferential Issue of shares & Issue Of Warrants & Increase in Autho ........
Tata Elxsi  
Audited Results & Dividend
Zenith Drugs  
Board Meeting Intimation
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.